Catalyst Wire Dossier Catalyst Wire Dossier

Multivalent Group B Streptococcus Vaccine

Group B Streptococcus vaccine (multivalent) · Pfizer
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Multivalent Group B Streptococcus Vaccine, covering 2019-07-02 to 2024-05-24. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women [Phase 2]

See pricing